 Press Release Distribution |
 |
- PR Home
- Latest News
- Feeds
- Alerts
- Submit Free Press Release
- Journalist Account
- PRNewswire Distribution
Filter News Show All ResultsNews By Country
News By Tag Sma  Related Tags Gmshrm
Health Hr Hrabc Hrpbc Human Resource Interview Phr Research Science Sekolah Rumah Shrm Sma America SMA Canada Smp Solar Solar Inverter Sphr Spinal Muscular Atrophy Sunny Boy
| sma Latest News+ XML/RSSBy SMA America SMA Volunteer Crew to Help Install Solar PV System at Home in Northern California By Families of SMA This funding will build on the consensus statement for the standard of care for SMA with data driven results on specific areas of SMA care such as respiratory, nutritional, and surgical interventions. By Families of SMA This three-year multi-million dollar cooperative agreement to Brian Kaspar, PhD, principal investigator in the Center for Gene Therapy at The Research Institute at Nationwide Children’s Hospital in the amount of $3,752,462, funds pre-clinical drug... By Families of SMA Repligen Corporation announced today that it has entered into an exclusive worldwide licensing agreement with Pfizer Inc. to advance Repligen’s spinal muscular atrophy (SMA) program, originally in-licensed from Families of SMA (FSMA). By Families of SMA The SMA community now has 3 clinical trials testing new SMA therapies, and an additional 10 programs in earlier stages of the drug development pipeline. By Mama Bracelets, LLC Mama Bracelets, LLC, an online jewelry business since 2010, re-opens its cyber doors after several weeks and keeps FSMA in its sight. By Fairview Microwave Fairview Microwave is now offering SMA PCB edge launch connectors for test applications By CBA, Corporate Benefit Advisors, LLC On Jan. 26, Concepcion Tuma, MSMHR, PHR, Miami Career Coach and GMSHRM’s HR Professional of the Year, 2011 Award Recipient, will be leading an exclusive workshop for local HR Pros in transition. By SMA America and SMA Canada Solar Industry Leader Releases New Event Schedule and Exclusive Educational Opportunities for the U.S. and Canada By FSMA Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 study of ISIS-SMNRx in patients with spinal muscular atrophy (SMA). Isis is developing ISIS-SMNRx as a potential treatment for all types of SMA. By CBA, Corporate Benefit Advisors, LLC On Nov. 2, Paula Kvarnberg, CEO and HR Consultant of Search America, LLC, will present on how to,“Turn an Interview into a Job Offer” an exclusive workshop for HR in Transition By Families of SMA Awards to help develop new therapies for SMA. These new awards encompass $745,000 for the basic research portion of the $3 Million in new research funding that FSMA announced earlier this year. By Corporate Benefit Advisors, LLC On Sept. 21, Communication and Presentation Skills Expert, Rosie Feeley will present,“It’s Not What You Say, It’s How You Say It: Interpersonal Communication Skills for Effective Interviewing” an exclusive workshop for local HR Pros By FSMA The new funding awards will be allocated into three distinct research areas: 1)Basic Research to understand the disease, 2)Drug Discovery to develop new SMA therapies, and 3)Clinical Research to provide the means to test new drugs effectively. All Press ReleasesBy SMA America Innovative Solution Offers Groundbreaking Design, Performance and Safety Features By Families of SMA This funding is being awarded to Co-Principal Investigators Dr. Arthur Burghes at Ohio State University and Dr. Christian Lorson at University of Missouri. By Families of SMA 15 new drugs now in development for SMA. 3 in active clinical trials. 11 companies investing in SMA drug programs. By SMA America SMA Volunteer Crew to Help Install Solar PV System at Home in Northern California By Families of SMA This funding will build on the consensus statement for the standard of care for SMA with data driven results on specific areas of SMA care such as respiratory, nutritional, and surgical interventions. By Families of SMA This three-year multi-million dollar cooperative agreement to Brian Kaspar, PhD, principal investigator in the Center for Gene Therapy at The Research Institute at Nationwide Children’s Hospital in the amount of $3,752,462, funds pre-clinical drug... By SMA America and SMA Canada SMA Partners with NABCEP as Exclusive Sponsor to Promote Solar Industry Education and Training By Families of SMA Dr. Rubin's project at Harvard is the first of three drug discovery awards that will be given by Families of SMA in the next few months. By Families of SMA Repligen Corporation announced today that it has entered into an exclusive worldwide licensing agreement with Pfizer Inc. to advance Repligen’s spinal muscular atrophy (SMA) program, originally in-licensed from Families of SMA (FSMA). By Families of SMA Families of SMA is dedicated to creating a treatment and cure for Spinal Muscular Atrophy by funding and advancing a comprehensive research program. By Families of SMA Continued investment in basic research leads to greater understanding of the exact nature, causes, and consequences of SMA. By Families of SMA This new research funding will support a project at Northwestern University to better understand when and where SMN protein is needed in less severe SMA. By Families of SMA This new research funding will support a project at Indiana University School of Medicine to better understand the role of SMN protein in motor axons. Families of Spinal Muscular Atrophy Awards New Research Funding to University of Southern California By Families of SMA This new research funding will support a project at the University of Southern California to better understand the role of astrocytes in SMA disease pathology. Families of Spinal Muscular Atrophy Awards New Research Funding of $140,000 to Dr. Charlotte Sumner. By FSMA This new research funding will support a project at Johns Hopkins University to learn more about motor axon growth in mouse models of SMA. By Families of SMA The SMA community now has 3 clinical trials testing new SMA therapies, and an additional 10 programs in earlier stages of the drug development pipeline. By SMA America Sunny Island Inverters Used in Mobile Charging Station to Fuel Record-Breaking Ride By www.spire-music.com TORONTO, ON (Oct. 31, 2012) - Mushy Callahan announced that it is hosting a music video release party, benefiting FightSMA Canada, for its new single “Shot Down”, starring Citytv’s Tom Hayes at the Velvet Underground on November 17, 2012 at 8pm By Families of SMA Repligen Corporation has initiated a Phase 1b clinical study of RG3039, a novel small molecule drug candidate for the potential treatment of spinal muscular atrophy (SMA). By SMA Canada Northland Power Inc. to Construct 13 Utility-Scale Solar Farms over the next 24 Months Families of SMA Announces $1.4Million Planned for Next Round of Spinal Muscular Atrophy Research Fun By Families of SMA Families of Spinal Muscular Atrophy (FSMA) is dedicated to creating a treatment and cure for Spinal Muscular Atrophy (SMA) by funding and advancing a comprehensive research program. By Mama Bracelets, LLC Mama Bracelets, LLC, an online jewelry business since 2010, re-opens its cyber doors after several weeks and keeps FSMA in its sight. By SMA America Solar Industry Leader Continues to Offer Exclusive Educational Opportunities for the US By Fairview Microwave Fairview Microwave is now offering SMA PCB edge launch connectors for test applications By Families of SMA Families of SMA is pleased to announce the award of up to $750,000 for an important new grant to Dr. Brian Kaspar at Nationwide Children’s Hospital. By Families of SMA The 12th annual Concert for a Cure event to be held on May 12th, 2012 is aiming to reach the incredible milestone of raising $1,000,000 for Spinal Muscular Atrophy (SMA) Research. By Families of SMA Repligen Corporation (NASDAQ:RGEN) today announced positive results from a Phase 1 study to evaluate the pharmacokinetic (PK) and safety profile of RG3039, a novel small molecule drug candidate for the potential treatment of SMA. By SMA America and SMA Canada Customizable Solution Saves Time, Reduces Costs with Designing Off-Grid PV Systems By SMA America and SMA Canada Solar Leader Introduces Preconfigured AC Distribution Hub for Off-Grid Renewable-Energy Systems By Families of SMA With the 9th Annual Jacob’s Run, Walk & Roll Event to be held on April 1st, The Jacob Isaac Rappoport Foundation is aiming to reach the milestone of raising $1,000,000 for Spinal Muscular Atrophy (SMA) Research. By SMA America Sunny Central Inverters to be an Integral Component of World’s Largest Photovoltaic Plant By SMA America and SMA Canada Free Smartphone Tool Provides PV System Data Anytime, Anywhere By SMA America Commercial and Utility-Scale Products from Denver Manufacturing Facility Now Meet “Buy American” Requirements By CBA, Corporate Benefit Advisors, LLC On Jan. 26, Concepcion Tuma, MSMHR, PHR, Miami Career Coach and GMSHRM’s HR Professional of the Year, 2011 Award Recipient, will be leading an exclusive workshop for local HR Pros in transition. By SMA America and SMA Canada Solar Industry Leader Releases New Event Schedule and Exclusive Educational Opportunities for the U.S. and Canada By Families of SMA Developing new therapies to treat and ultimately cure SMA is the driving force behind Families of SMA. To achieve this goal, Families of SMA aggressively invests in drug development research. By Families of SMA Nutrition Basics: Fostering Health and Growth for Spinal Muscular Atrophy is Families of SMA’s newest release of the SMA Care Series Booklets, which are provided free of charge to all SMA families, as well as SMA Care Providers worldwide. By SMA America International Standards Address Fundamentals of Quality and Environmental Management Systems By FSMA Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 study of ISIS-SMNRx in patients with spinal muscular atrophy (SMA). Isis is developing ISIS-SMNRx as a potential treatment for all types of SMA. By SLK Creative The second annual A Toy's Story 2: A Night for Giving will take place December 14th at The Manor. The event will benefit seven South Florida charities, hold auctions, and provide the community an opportunity to become familiar with local charities. By CBA, Corporate Benefit Advisors, LLC On Nov. 10, The Greater Miami SHRM Associaton Coffee Break Series will join forces with the Competitive Edge: Advanced Job Search Tools for HR in Transition to co-host an interactive workshop in Dade County By CBA, Corporate Benefit Advisors, LLC On Nov. 2, Paula Kvarnberg, CEO and HR Consultant of Search America, LLC, will present on how to,“Turn an Interview into a Job Offer” an exclusive workshop for HR in Transition By Families of SMA Awards to help develop new therapies for SMA. These new awards encompass $745,000 for the basic research portion of the $3 Million in new research funding that FSMA announced earlier this year. By Mama Bracelets, LLC Mama Bracelets has already raised over $500 through their exclusive “Cure SMA” Bracelets for SMA Research By Corporate Benefit Advisors, LLC On Sept. 21, Communication and Presentation Skills Expert, Rosie Feeley will present,“It’s Not What You Say, It’s How You Say It: Interpersonal Communication Skills for Effective Interviewing” an exclusive workshop for local HR Pros By Mama Bracelets, LLC Mama Bracelets' owners launch SMA Awareness bracelets in efforts to fund research to cure SMA as their daughter has been recently diagnosed with SMA Type 2. By SMA America and SMA Canada Inverter System Ideal for Commercial-Scale PV Systems By SMA America and SMA Canada Solar Industry Leader to Bring Technical Training, Marketing Solutions and Hands-on Product Workshops to Select Cities By Bob Hawkins Fairview Microwave acaba de introducir la series SA3015 de atenuadores SMA. By SMA Canada Ontario-assembled Inverters now Approved for use Down to -40 Celsius | ||||||||||||||||||||||
Like PRLog?
8.4K1.9K2.6K